{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:53:56Z","timestamp":1790420036668,"version":"4.1.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1995,3,1]],"date-time":"1995-03-01T00:00:00Z","timestamp":794016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T00:00:00Z","timestamp":1577404800000},"content-version":"vor","delay-in-days":9067,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1995,3]]},"DOI":"10.1093\/oxfordjournals.annonc.a059162","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T12:25:23Z","timestamp":1486124723000},"page":"300-301","source":"Crossref","is-referenced-by-count":37,"title":["Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anemia"],"prefix":"10.1016","volume":"6","author":[{"given":"J.C.","family":"Byrd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.","family":"Hertler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.B.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Freiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.L.","family":"Kweder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.F.","family":"Diehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/oxfordjournals.annonc.a059162_bb0060","first-page":"3","article-title":"X-radiation and alkylating agents as possible \u2018trigger\u2019 mechanisms in autoimmune complications of malignant lymphoproliferative disease","volume":"1","author":"Lewis","year":"1966","journal-title":"Clin Exp Immunol"},{"key":"10.1093\/oxfordjournals.annonc.a059162_bb0065","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ajh.2830430406","article-title":"Mechanisms of autoimmune hemolytic anemia in chronic lymphocytic leukemia","volume":"43","author":"Sthoeger","year":"1993","journal-title":"Am J Hematol"},{"key":"10.1093\/oxfordjournals.annonc.a059162_bb0070","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/ajh.2830320314","article-title":"Case report Allergic reaction with immune hemolytic anemia resulting from chlorambucil","volume":"32","author":"Thompson-Noya","year":"1989","journal-title":"Am J Hematol"},{"key":"10.1093\/oxfordjournals.annonc.a059162_bb0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/10428199309054731","article-title":"Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine","volume":"11","author":"Di Raimondo","year":"1993","journal-title":"Leuk Lymph"},{"key":"10.1093\/oxfordjournals.annonc.a059162_bb0080","first-page":"304","article-title":"Fludarabine therapy for lymphoid malignancies is associated with hemolytic anemia","volume":"13","author":"Byrd","year":"1994","journal-title":"Am Soc Chn Oncol"},{"key":"10.1093\/oxfordjournals.annonc.a059162_bb0085","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/jama.1955.02960080005002","article-title":"Dysplenism secondary to chronic leukemia or malignant lymphoma","volume":"158","author":"Reinhard","year":"1955","journal-title":"J Am Med Assoc"},{"key":"10.1093\/oxfordjournals.annonc.a059162_bb0090","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/ajcp\/37.5.491","article-title":"Splenectomy in leukemia and myelofibrosis: Changes in the erythrocyte values","volume":"37","author":"Strumia","year":"1962","journal-title":"Am J Clin Pathol"},{"key":"10.1093\/oxfordjournals.annonc.a059162_bb0095","first-page":"461a","article-title":"The hematologic and survival benefits of splenectomy in chronic lymphocytic leukemia (CLL): A case\/control study","volume":"84","author":"Seymour","year":"1994","journal-title":"Blood"},{"key":"10.1093\/oxfordjournals.annonc.a059162_bb0100","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/jnci\/83.22.1678","article-title":"Kinetics of recovery of CD4+ T cells in peripheral blood of deoxycoformycin-treated patient","volume":"83","author":"Steis","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/oxfordjournals.annonc.a059162_bb0105","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1600-0609.1993.tb00165.x","article-title":"Severe immunodeficiency in patients treated with fludarabine monophosphate","volume":"50","author":"Wijermans","year":"1993","journal-title":"Eur J Haematol"},{"key":"10.1093\/oxfordjournals.annonc.a059162_bb0110","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0145-2126(82)90096-0","article-title":"Effect of therapy on T cell subpopulations in patients with chronic lymphocytic leukemia","volume":"6","author":"Kay","year":"1982","journal-title":"Leuk Res"},{"key":"10.1093\/oxfordjournals.annonc.a059162_bb0115","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1200\/JCO.1989.7.4.433","article-title":"Pentostatin in chronic lymphocytic leukemia: A phase II trial of Cancer and Leukemia Group B","volume":"7","author":"Dillman","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1093\/oxfordjournals.annonc.a059162_bb0120","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1200\/JCO.1985.3.9.1196","article-title":"Low-dose deoxycoformycin in lymphoid malignancy","volume":"3","author":"Grever","year":"1985","journal-title":"J Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419611713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419611713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/6\/3\/300\/372400\/6-3-300.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T20:12:55Z","timestamp":1582229575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419611713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,3]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,3]]}},"alternative-id":["S0923753419611713"],"URL":"https:\/\/doi.org\/10.1093\/oxfordjournals.annonc.a059162","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1995,3]]}}}